LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

Kodu・Aktsiate loetelu・Intuitive Surgical Inc

Intuitive Surgical Inc

Suletud

SektorTervishoid

424.07 0.17

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

419.65

Max

425.8

Põhinäitajad
By Trading Economics
Sissetulek	22M 822M
Müük	-95M 2.8B
P/E Sektori keskmine	53.168 50.102
Aktsiakasum	2.5
Kasumimarginaal	29.648
Töötajad	17,021
EBITDA	-230M 855M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+34.46% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	21. juuli 2026

Turustatistika
By TradingEconomics
Turukapital	-10B 155B
Eelmine avamishind	423.9
Eelmine sulgemishind	424.07

Uudiste sentiment

By Acuity

39%

61%

79 / 344 Pingereas Healthcare

Intuitive Surgical Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. apr 2026, 15:47 UTC

Suurimad hinnamuutused turgudel

Intuitive Surgical Shares Rise After 1Q Beat

21. apr 2026, 20:54 UTC

Tulu

Intuitive Surgical Posts Higher 1Q Sales, Profit

22. apr 2026, 11:27 UTC

Tulu

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

21. apr 2026, 21:14 UTC

Tulu

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

21. apr 2026, 20:38 UTC

Tulu

Intuitive Surgical 1Q Rev $2.77B >ISRG

21. apr 2026, 20:38 UTC

Tulu

Intuitive Surgical 1Q Net $821.5M >ISRG

21. apr 2026, 20:38 UTC

Tulu

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 431.00 >ISRG

21. apr 2026, 20:38 UTC

Tulu

Intuitive Surgical 1Q Adj EPS $2.50 >ISRG

21. apr 2026, 20:38 UTC

Tulu

Intuitive Surgical 1Q EPS $2.28 >ISRG

21. apr 2026, 20:14 UTC

Tulu

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of About 13.5% to 15.5%

21. apr 2026, 20:14 UTC

Tulu

Intuitive Surgical 1Q Rev $2.77B

21. apr 2026, 20:13 UTC

Tulu

Intuitive Surgical 1Q Adj EPS $2.50

21. apr 2026, 20:12 UTC

Tulu

Intuitive Surgical 1Q EPS $2.28

14. apr 2026, 14:13 UTC

Tulu

Johnson & Johnson Financial Chief Sees 'Clear Line of Sight' to Double-Digit Growth by 2030 -- Barrons.com

14. apr 2026, 12:57 UTC

Tulu

Johnson & Johnson Financial Chief Sees 'Clear Line of Sight' to Double-Digit Growth by 2030 -- Barrons.com

17. veebr 2026, 14:48 UTC

Tulu

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

23. jaan 2026, 16:07 UTC

Tulu

Intuitive Surgical Stock Beats Earnings Estimates. The Stock Is Barely Moving. -- Barrons.com

23. jaan 2026, 12:58 UTC

Tulu

Intuitive Surgical Stock Rises on Earnings. What Wall Street Is Saying. -- Barrons.com

22. jaan 2026, 21:11 UTC

Tulu

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22. jaan 2026, 21:11 UTC

Tulu

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22. jaan 2026, 21:10 UTC

Tulu

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22. jaan 2026, 21:05 UTC

Tulu

Intuitive Surgical 4Q EPS $2.21 >ISRG

22. jaan 2026, 21:05 UTC

Tulu

Intuitive Surgical 4Q Rev $2.87B >ISRG

22. jaan 2026, 21:05 UTC

Tulu

Intuitive Surgical 4Q Net $794.8M >ISRG

22. jaan 2026, 21:05 UTC

Tulu

Intuitive Surgical 4Q Adj EPS $2.53 >ISRG

22. jaan 2026, 21:05 UTC

Tulu

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 532.00 >ISRG

30. okt 2025, 12:38 UTC

Tulu

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

30. okt 2025, 12:01 UTC

Tulu

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

22. okt 2025, 15:42 UTC

Tulu

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

22. okt 2025, 12:34 UTC

Tulu

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Intuitive Surgical Inc Prognoos

Hinnasiht

By TipRanks

34.46% tõus

12 kuu keskmine prognoos

Keskmine 569.61 USD 34.46%

Kõrge 670 USD

Madal 451 USD

Põhineb 20 Wall Streeti analüütiku instrumendi Intuitive Surgical Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

20 ratings

Osta

Hoia

Müü

Põhineb 20 analüütiku instrumendi Intuitive Surgical Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

79 / 344 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.